Takeda San Francisco has licensed Ariadne’s Pathway Studio software.
The biologics discovery arm of Takeda plans to use the software to support its therapeutics discovery for cancer, inflammatory disease, and metabolic disease.
ChemAxon said that the Broad Institute will license its platform, discovery toolkits, and desktop applications for institute-wide use.
Specifically, the Broad will use ChemAxon's technology, including the JChem toolkit, to support its small-molecule registration system and other aspects of its Chemical Biology Platform.
The Catholic Health Initiatives’ Institutes for Research and Innovation’s Center for Translational Research will use BioFortis's Labmatrix software as part of its personalized medicine research effort.
Labmatrix is a web-based software that lets users manage and integrate clinical, specimen, and molecular assay datasets and interface the data with other systems such as electronic medical records, genomic or proteomic databases, and laboratory information management systems.
As part of the agreement, the partners plan to integrate the software with in-network hospitals’ electronic medical records systems.